Affinity Asset Advisors, LLC Q2 2021 Filing
Filed August 13, 2021
Portfolio Value
$279.3B
Holdings
69
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (69 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | BBIOBRIDGEBIO PHARMA INC | 550,000 | $33.5B | 12.00% | |
| 2 | XBISPDR SER TR | 200,000 | $27.1B | 9.69% | Put |
| 3 | ARKGARK ETF TR | 225,000 | $20.8B | 7.45% | Put |
| 4 | MORFMORPHIC HLDG INC | 246,201 | $14.1B | 5.06% | |
| 5 | CVACCUREVAC N V | 150,000 | $11.0B | 3.95% | Put |
| 6 | —VINCERX PHARMA INC | 838,311 | $10.9B | 3.90% | |
| 7 | NAUTNAUTILUS BIOTECHNOLOGY INC | 900,000 | $9.1B | 3.25% | |
| 8 | KURAKURA ONCOLOGY INC | 425,000 | $8.9B | 3.17% | |
| 9 | NARIUSDINARI MED INC | 85,000 | $7.9B | 2.84% | |
| 10 | ZNTLZENTALIS PHARMACEUTICALS INC | 142,418 | $7.6B | 2.71% | |
| 11 | —ARYA SCIENCES ACQU CORP IV | 700,000 | $7.5B | 2.69% | |
| 12 | XLRNACCELERON PHARMA INC | 55,000 | $6.9B | 2.47% | |
| 13 | PTGXPROTAGONIST THERAPEUTICS INC | 140,100 | $6.3B | 2.25% | |
| 14 | TVTX 2.5 09/15/25RETROPHIN INC | 7,000,000 | $6.0B | 2.15% | |
| 15 | RCKTROCKET PHARMACEUTICALS INC | 120,000 | $5.3B | 1.90% | |
| 16 | —CURIS INC | 650,000 | $5.2B | 1.88% | |
| 17 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 200,000 | $5.1B | 1.83% | |
| 18 | ACRSACLARIS THERAPEUTICS INC | 275,000 | $4.8B | 1.73% | |
| 19 | ALNYALNYLAM PHARMACEUTICALS INC | 25,000 | $4.2B | 1.52% | Call |
| 20 | OCULOCULAR THERAPEUTIX INC | 250,000 | $3.5B | 1.27% | |
| 21 | —HEALTH SCIENCES ACQ CORP 2 | 300,000 | $3.1B | 1.10% | |
| 22 | ISIIONIS PHARMACEUTICALS INC | 75,000 | $3.0B | 1.07% | Call |
| 23 | MRNAMODERNA INC | 12,500 | $2.9B | 1.05% | Call |
| 24 | —MEDICUS SCIENCES ACQUISITION | 300,000 | $2.9B | 1.04% | |
| 25 | 290ACHINOOK THERAPEUTICS INC | 200,000 | $2.8B | 1.01% | |
| 26 | LUNGPULMONX CORP | 60,000 | $2.6B | 0.95% | |
| 27 | ASNDASCENDIS PHARMA A/S | 20,000 | $2.6B | 0.94% | |
| 28 | IOVAIOVANCE BIOTHERAPEUTICS INC | 100,000 | $2.6B | 0.93% | |
| 29 | HZNPHORIZON THERAPEUTICS PUB L | 25,000 | $2.3B | 0.84% | |
| 30 | ALDXALDEYRA THERAPEUTICS INC | 200,000 | $2.3B | 0.81% | |
| 31 | —CYCLACEL PHARMACEUTICALS INC | 380,000 | $2.3B | 0.81% | |
| 32 | MGNXMACROGENICS INC | 80,000 | $2.1B | 0.77% | |
| 33 | MREOMEREO BIOPHARMA GROUP PLC | 650,000 | $2.1B | 0.74% | |
| 34 | SWTXSPRINGWORKS THERAPEUTICS INC | 25,000 | $2.1B | 0.74% | |
| 35 | EPIEURESSA PHARMA INC | 70,000 | $2.0B | 0.72% | |
| 36 | SDGRSCHRODINGER INC | 25,000 | $1.9B | 0.68% | |
| 37 | ESTAESTABLISHMENT LABS HLDGS INC | 20,000 | $1.7B | 0.63% | |
| 38 | AXSMAXSOME THERAPEUTICS INC | 25,000 | $1.7B | 0.60% | |
| 39 | TCE2CELLDEX THERAPEUTICS INC NEW | 50,000 | $1.7B | 0.60% | |
| 40 | NTLAINTELLIA THERAPEUTICS INC | 10,000 | $1.6B | 0.58% | |
| 41 | GOSS 5 06/01/27GOSSAMER BIO INC | 2,000,000 | $1.6B | 0.57% | |
| 42 | —LIFESCI ACQUISITION II CORP | 150,000 | $1.5B | 0.54% | |
| 43 | CNTACENTESSA PHARMACEUTICALS PLC | 66,957 | $1.5B | 0.53% | |
| 44 | BFLYBUTTERFLY NETWORK INC | 100,000 | $1.4B | 0.52% | |
| 45 | GLPGGALAPAGOS NV | 20,000 | $1.4B | 0.50% | |
| 46 | CYTKCYTOKINETICS INC | 70,000 | $1.4B | 0.50% | |
| 47 | AFIBACUTUS MED INC | 80,000 | $1.4B | 0.49% | |
| 48 | KALVKALVISTA PHARMACEUTICALS INC | 50,000 | $1.2B | 0.43% | |
| 49 | CGEMCULLINAN ONCOLOGY INC | 45,000 | $1.2B | 0.41% | |
| 50 | —MERSANA THERAPEUTICS INC | 85,000 | $1.2B | 0.41% | |
| 51 | —BCTG ACQUISITION CORP | 100,000 | $1.1B | 0.41% | |
| 52 | PCVXVAXCYTE INC | 50,000 | $1.1B | 0.40% | |
| 53 | —CEREVEL THERAPEUTICS HLDNG I | 72,466 | $1.0B | 0.37% | |
| 54 | —ZYMEWORKS INC | 30,000 | $1.0B | 0.37% | |
| 55 | NSTGEURNANOSTRING TECHNOLOGIES INC | 15,000 | $972.0M | 0.35% | |
| 56 | BLUBELLUS HEALTH INC NEW | 300,000 | $933.0M | 0.33% | |
| 57 | QSIQUANTUM SI INC | 75,000 | $920.0M | 0.33% | |
| 58 | —CHARDAN HEALTHCR ACQSTN 2 CO | 75,000 | $819.0M | 0.29% | |
| 59 | 698ACHILLES THERAPEUTICS PLC | 80,000 | $783.0M | 0.28% | |
| 60 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 20,000 | $700.0M | 0.25% | |
| 61 | —HARPOON THERAPEUTICS INC | 50,000 | $694.0M | 0.25% | |
| 62 | IMTXIMMATICS N.V | 190,000 | $654.0M | 0.23% | |
| 63 | 5E7ITEOS THERAPEUTICS INC | 25,000 | $641.0M | 0.23% | |
| 64 | APLSAPELLIS PHARMACEUTICALS INC | 10,000 | $632.0M | 0.23% | |
| 65 | CTMXCYTOMX THERAPEUTICS INC | 75,000 | $475.0M | 0.17% | |
| 66 | IMVTIMMUNOVANT INC | 30,000 | $317.0M | 0.11% | Call |
| 67 | —THE BEAUTY HEALTH COMPANY | 45,000 | $288.0M | 0.10% | |
| 68 | CVRXCVRX INC | 7,500 | $210.0M | 0.08% | |
| 69 | —MEDICUS SCIENCES ACQUISITION | 33,333 | $34.0M | 0.01% |